NO20030373D0 - Medicines containing cilantrone for the treatment of non-constipated male IBS patients - Google Patents

Medicines containing cilantrone for the treatment of non-constipated male IBS patients

Info

Publication number
NO20030373D0
NO20030373D0 NO20030373A NO20030373A NO20030373D0 NO 20030373 D0 NO20030373 D0 NO 20030373D0 NO 20030373 A NO20030373 A NO 20030373A NO 20030373 A NO20030373 A NO 20030373A NO 20030373 D0 NO20030373 D0 NO 20030373D0
Authority
NO
Norway
Prior art keywords
cilantrone
constipated
treatment
ibs patients
medicines containing
Prior art date
Application number
NO20030373A
Other languages
Norwegian (no)
Other versions
NO20030373L (en
Inventor
Werner Cautreels
Claus Rudolf Steinborn
Heinz Guenter Krause
Steven David Caras
Egbertus Hendrikus Biesheuvel
Albertus Hermannus Plekkenpol
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10123447A external-priority patent/DE10123447A1/en
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO20030373L publication Critical patent/NO20030373L/en
Publication of NO20030373D0 publication Critical patent/NO20030373D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20030373A 2000-07-26 2003-01-24 Medicines containing cilantrone for the treatment of non-constipated male IBS patients NO20030373D0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10036645 2000-07-26
DE10123447A DE10123447A1 (en) 2000-07-26 2001-05-14 Cilansetron-containing medicines for the treatment of non-obstipative male IBS patients
PCT/EP2001/008260 WO2002007713A2 (en) 2000-07-26 2001-07-18 Medicaments containing cilansetron for treating non-obstipated male ibs patients

Publications (2)

Publication Number Publication Date
NO20030373L NO20030373L (en) 2003-01-24
NO20030373D0 true NO20030373D0 (en) 2003-01-24

Family

ID=26006529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030373A NO20030373D0 (en) 2000-07-26 2003-01-24 Medicines containing cilantrone for the treatment of non-constipated male IBS patients

Country Status (16)

Country Link
EP (1) EP1307195A2 (en)
JP (1) JP2004504343A (en)
CN (1) CN1444479A (en)
AR (1) AR028970A1 (en)
AU (1) AU2001276409A1 (en)
BR (1) BR0112690A (en)
CA (1) CA2417677A1 (en)
CZ (1) CZ2003158A3 (en)
HU (1) HUP0301479A2 (en)
IL (1) IL153972A0 (en)
MX (1) MXPA02012917A (en)
NO (1) NO20030373D0 (en)
PL (1) PL363517A1 (en)
RU (1) RU2003104798A (en)
SK (1) SK1272003A3 (en)
WO (1) WO2002007713A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
CA2516433C (en) * 2004-01-30 2009-06-02 Astellas Pharma Inc. Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
WO2005073220A1 (en) * 2004-01-30 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. Remedy for irritable bowel syndrome with diarrhea
JP4632204B2 (en) * 2005-09-21 2011-02-16 アステラス製薬株式会社 Antidiarrheal irritable bowel syndrome treatment
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
CZ2003158A3 (en) 2003-08-13
AR028970A1 (en) 2003-05-28
EP1307195A2 (en) 2003-05-07
WO2002007713A2 (en) 2002-01-31
IL153972A0 (en) 2003-07-31
RU2003104798A (en) 2004-06-27
MXPA02012917A (en) 2003-05-14
HUP0301479A2 (en) 2003-09-29
NO20030373L (en) 2003-01-24
WO2002007713A3 (en) 2002-11-14
CA2417677A1 (en) 2003-01-27
SK1272003A3 (en) 2003-07-01
CN1444479A (en) 2003-09-24
JP2004504343A (en) 2004-02-12
BR0112690A (en) 2003-06-24
AU2001276409A1 (en) 2002-02-05
PL363517A1 (en) 2004-11-29

Similar Documents

Publication Publication Date Title
NO20014379D0 (en) Use of Xenon for the Treatment of Neurointoxics
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
DE60115418D1 (en) MICROINFUSION DEVICE FOR THE ADMINISTRATION OF MEDICAMENTS
IS6994A (en) Aripiprazole solution for oral administration
IL196301A0 (en) Medicament for the treatment of hapatitis c
NO20044054L (en) Administration of agents for the treatment of inflammation
IS6616A (en) Set bicyclic derivatives for the treatment of aberrant cell growth
ATE296619T1 (en) SOLID ORAL DOSAGE FORM OF SIMETHICON
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20013958L (en) Medication for the treatment of high blood pressure
NO20023482D0 (en) Procedure for the treatment of substance abuse
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
FI20000780A (en) Oral dosage form for controlled release of the drug
NO20024776D0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20024777L (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20026219L (en) Compounds for the treatment of impaired fundic relaxation
IS6172A (en) Use of melatonin for medicinal purposes
NO20030373L (en) Medicines containing cilantrone for the treatment of non-constipated male IBS patients
NO20020784D0 (en) Medication for the treatment of fractures
NO20012541D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20013651D0 (en) Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections
NO20042476L (en) Use of desoxypeganine for the treatment of clinical depression
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
NO20030717L (en) Compounds for the treatment of addiction disorders
IS6360A (en) Medicines for the treatment of hepatitis C

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application